Stephanie Horn-Warnock, newly appointed CFO, Treasurer, and Corporate Secretary of Tempest Therapeutics, Inc., filed an initial statement of beneficial ownership with the SEC on November 3, 2026, reporting no securities beneficially owned as of the event date of October 26, 2026.

Key Highlights

  • Reporting person: Stephanie Horn-Warnock, identified in the filing as CFO, Treasurer, and Corporate Secretary of Tempest Therapeutics, Inc. (NASDAQ:TPST).
  • Event date: The date of the event requiring the statement is listed as October 26, 2026.
  • No securities held: The filing states "No securities are beneficially owned" in both the non-derivative and derivative securities tables.
  • Filing type: This is an initial statement of beneficial ownership, filed individually by one reporting person.
  • Filing date: The form was signed and filed on November 3, 2026.

Horn-Warnock Reports Zero Initial Holdings at Tempest Therapeutics

Stephanie Horn-Warnock submitted a Form 3 initial statement of beneficial ownership to the SEC on November 3, 2026, following her commencement of a reporting obligation as an officer of Tempest Therapeutics, Inc. (NASDAQ:TPST). According to the filing, the event requiring the statement occurred on October 26, 2026, the date she assumed her role as CFO, Treasurer, and Corporate Secretary.

The filing discloses no holdings in either Table I, covering non-derivative securities, or Table II, covering derivative securities such as options, warrants, or convertible instruments. The explanation of responses section states explicitly: "No securities are beneficially owned." Both direct and indirect ownership categories show no entries.

The form was filed individually by Horn-Warnock as a single reporting person. Her address of record listed in the filing is 603 Oak Branch Lane, Mount Juliet, Tennessee 37122. The filing was submitted pursuant to Section 16(a) of the Securities Exchange Act of 1934, which requires officers, directors, and certain shareholders to report their initial beneficial ownership upon becoming subject to that obligation.

What Was Disclosed

Stephanie Horn-Warnock filed a Form 3 with the SEC on November 3, 2026, disclosing her initial beneficial ownership position as CFO, Treasurer, and Corporate Secretary of Tempest Therapeutics, Inc. The filing reports no securities of any kind beneficially owned as of October 26, 2026.